Literature DB >> 19887750

18F-fluorodeoxyglucose positron emission tomography and magnetic resonance imaging findings of primary intracranial histiocytic sarcoma in a dog.

Byeong-Teck Kang1, Chul Park, Jong-Hyun Yoo, Su-Hyun Gu, Dong-Pyo Jang, Young-Bo Kim, Eung-Je Woo, Dae-Young Kim, Zang-Hee Cho, Hee-Myung Park.   

Abstract

A 10-year-old, neutered male, Maltese dog presented with a three week history of intention tremor, right hind limb rigidity, poor coordination, and occasional circling to the left. On magnetic resonance imaging (MRI) of the brain, a mass was identified in the right occipital lobe and cerebellum. Three weeks after the initial MRI scan, we performed an (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) of the brain. The FDG-PET demonstrated areas of hypermetabolism in the right occipital lobe, cerebellum, pons, and medulla oblongata. When the standardized uptake value was calculated, the hypermetabolic lesion was higher than the gray matter values. The anatomical location of the hypermetabolic lesion was more precisely identified by the PET-MRI fusion images. The dog was definitively diagnosed as a primary histiocytic sarcoma of the brain. This is the first report of PET findings of an intracranial histiocytic sarcoma in a dog.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19887750     DOI: 10.1292/jvms.001397

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  6 in total

1.  Characteristics of 18F-FDG and 18F-FDOPA PET in an 8-year-old neutered male Yorkshire Terrier dog with glioma: long-term chemotherapy using hydroxyurea plus imatinib with prednisolone and immunoreactivity for PDGFR-β and LAT1.

Authors:  Taesik Yun; Yoonhoi Koo; Sanggu Kim; Wonguk Lee; Hakhyun Kim; Dongwoo Chang; Soochong Kim; Mhan-Pyo Yang; Byeong-Teck Kang
Journal:  Vet Q       Date:  2021-12       Impact factor: 3.320

2.  Comparative Oncology: Evaluation of 2-Deoxy-2-[18F]fluoro-D-glucose (FDG) Positron Emission Tomography/Computed Tomography (PET/CT) for the Staging of Dogs with Malignant Tumors.

Authors:  Stefanie M F Seiler; Christine Baumgartner; Johannes Hirschberger; Ambros J Beer; Andreas Brühschwein; Nina Kreutzmann; Silja Laberke; Melanie C Wergin; Andrea Meyer-Lindenberg; Johanna Brandl; Anne-Kathrin von Thaden; Eliane Farrell; Markus Schwaiger
Journal:  PLoS One       Date:  2015-06-12       Impact factor: 3.240

3.  Histiocytic sarcoma with central nervous system involvement in dogs: 19 cases (2006-2012).

Authors:  C L Mariani; M K Jennings; N J Olby; L B Borst; J C Brown; I D Robertson; G S Seiler; E MacKillop
Journal:  J Vet Intern Med       Date:  2015-02-25       Impact factor: 3.333

Review 4.  Recent Advances in Radiotracer Imaging Hold Potential for Future Refined Evaluation of Epilepsy in Veterinary Neurology.

Authors:  Marion Bankstahl; Jens P Bankstahl
Journal:  Front Vet Sci       Date:  2017-12-13

Review 5.  Companion animal models of neurological disease.

Authors:  Brittanie Partridge; John H Rossmeisl
Journal:  J Neurosci Methods       Date:  2019-11-13       Impact factor: 2.390

Review 6.  Advances in diagnostic and treatment modalities for intracranial tumors.

Authors:  P J Dickinson
Journal:  J Vet Intern Med       Date:  2014-05-09       Impact factor: 3.333

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.